|
|
|
|
|
|
|
23.01.26 - 20:31
|
XFRA: Deletion of Instruments from Boerse Frankfurt - 23.01.2026 (XETRA)
|
|
|
The following instruments on Boerse Frankfurt do have their last trading day on 23.01.2026
Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 23.01.2026
ISIN Name
DK0063631999 DANCANN PHARMA DK 1
GB00BS457501 CORO ENERGY PLC LS-,005
US29873D1046 EUROBK ERGAS.ADR 1/2 NEW
US7242495031 PIRAEUS F.HL.ADR NEW 2021
XS2462605671 TEL.EUROPE 22/UND. FLR...
|
|
|
18.12.25 - 09:01
|
XFRA: EFGA: Wiederaufnahme/Resumption (XETRA)
|
|
|
FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.
THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:
INSTRUMENT NAME KUERZEL/SHORTCODE ISIN
EUROBK ERGAS.ADR 1/2 NEW EFGA US29873D1046
AB/FROM ONWARDS 18.12.2025 08:35 CET...
|
|
|
|
|
12.12.25 - 20:24
|
XFRA: Deletion of Instruments from Boerse Frankfurt - 12.12.2025 (XETRA)
|
|
|
The following instruments on Boerse Frankfurt do have their last trading day on 12.12.2025.
Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 12.12.2025.
ISIN Name
CA1850534027 CLEARMIND MEDI.INC.O.N.
GB00BR3SVZ18 MERIDIAN MINING SE
GRS323003012 EUROBANK ERGASIAS EO-,22
TH0975010R11 BANGCHAK S-NVDR- BA4,9338
US16115Q3083 CHART INDS INC. DL-,01
US23204G7043 CUSTOMERS BANC.PRF.F DL25
US75973T1016 RENALYTIX SP.ADS/2
XS1649193403 AROUNDTOWN 17/26 MTN...
|
|
|
|
|
11.12.25 - 11:39
|
XFRA: EFGA: Aussetzung/Suspension (XETRA)
|
|
|
DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:
THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:
INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL
EUROBK ERGAS.ADR 1/2 NEW EFGA US29873D1046 BAW/UFN...
|
|
|
|
|
10.12.25 - 10:12
|
XFRA: EFGD: Aussetzung/Suspension (XETRA)
|
|
|
DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:
THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:
INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL
EUROBANK ERGASIAS EO-,22 EFGD GRS323003012 BAW/UFN...
|
|
|
|
|
|
|
06.11.25 - 23:51
|
XFRA: DIVIDEND/INTEREST INFORMATION - 10.11.2025 - US29873D1046 (XETRA)
|
|
|
Das Instrument EFGA US29873D1046 EUROBK ERGAS.ADR 1/2 NEW EQUITY wird cum Dividende/Zinsen gehandelt am 07.11.2025 und ex Dividende/Zinsen am 10.11.2025
The instrument EFGA US29873D1046 EUROBK ERGAS.ADR 1/2 NEW EQUITY has its pre-dividend/interest day on 07.11.2025 and its ex-dividend/interest day on 10.11.2025...
|
|
|
05.11.25 - 00:01
|
XFRA: DIVIDEND/INTEREST INFORMATION - 06.11.2025 - GRS323003012 (XETRA)
|
|
|
Das Instrument EFGD GRS323003012 EUROBANK ERGASIAS EO-,22 EQUITY wird cum Dividende/Zinsen gehandelt am 05.11.2025 und ex Dividende/Zinsen am 06.11.2025
The instrument EFGD GRS323003012 EUROBANK ERGASIAS EO-,22 EQUITY has its pre-dividend/interest day on 05.11.2025 and its ex-dividend/interest day on 06.11.2025...
|
|
|
|
|
30.10.25 - 17:00
|
Egypt: Egypt′s Karm Expands Internationally With $5.8m Cyprus Solar Project (AllAfrica)
|
|
|
[Daba Finance] Egypt-based renewable energy utility Karm (KarmSolar) has announced its first international expansion with the launch of KarmCyprus The company secured €5 million in project financing from Eurobank to build a 7.6 MW solar photovoltaic plant in Monagroulli, southern Cyprus The expansion mirrors Karm's vertically integrated model across power generation, distribution, storage, and e-mobility...
|
|
|
13.10.25 - 08:03
|
Fairfax Sells Interest in Eurolife Life Insurance Operations to Eurobank (GlobeNewswire EN)
|
|
|
TORONTO, Oct. 13, 2025 (GLOBE NEWSWIRE) -- Fairfax Financial Holdings Limited (TSX: FFH and FFH.U) announces that it has entered into a term sheet with Eurobank Ergasias Services and Holdings S.A. (“Eurobank”) pursuant to which Eurobank or an affiliate thereof will acquire from certain affiliates of Fairfax Financial Holdings Limited (collectively, “Fairfax”) the 80% equity interest owned by Fairfax in the life insurance business operated by Eurolife FFH Insurance Group Holdings S.A. (“Eurolife”) for cash consideration of €813 million....
|
|